Fulminant Myocarditis
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 9 references indexed in Scilit:
- Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic DysfunctionJACC, 2019
- National Trends and Outcomes of Endomyocardial Biopsy for Patients With Myocarditis: From the National Inpatient Sample DatabaseJournal of Cardiac Failure, 2018
- Increased reporting of fatal immune checkpoint inhibitor-associated myocarditisThe Lancet, 2018
- Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute MyocarditisCirculation, 2017
- Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseEuropean Heart Journal, 2017
- Fulminant Myocarditis with Combination Immune Checkpoint BlockadeNew England Journal of Medicine, 2016
- viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemiaNature Biotechnology, 2013
- The Role of Endomyocardial Biopsy in the Management of Cardiovascular DiseaseJACC, 2007
- Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) MyocarditisNew England Journal of Medicine, 2000